Skip to main navigation
Skip to search
Skip to main content
University of Haifa Home
Update your profile
Link opens in a new tab
Search content at University of Haifa
Home
Researchers
Research units
Research output
Prevention and treatment of motion sickness in children
Carlos R. Gordon
,
Avi Shupak
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prevention and treatment of motion sickness in children'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Motion Sickness
100%
Pharmacological Treatment
23%
Sickness
15%
Active Treatment
15%
Unnatural
15%
Moving Stimuli
15%
Brainstem
7%
Neurochemicals
7%
Most Common Form
7%
Agent-based
7%
Vertigo
7%
Pediatric Population
7%
Preventive Treatment
7%
Peripheral Vestibular
7%
Antihistamines
7%
Vestibular nuclei
7%
Normal Response
7%
Dimenhydrinate
7%
Cinnarizine
7%
Promethazine
7%
Amusement Park
7%
Sensory Mismatch
7%
Parenteral Administration
7%
Anti-motion Sickness Drugs
7%
Cyclizine
7%
Transient Response
7%
Non-pharmacological Measures
7%
Rectal Administration
7%
Vestibular Suppressants
7%
Vomiting Center
7%
Neuroscience
Drug Therapy
100%
Brainstem
33%
Vestibular Nucleus
33%
Cinnarizine
33%
Dimenhydrinate
33%
Antihistamines
33%
Promethazine
33%
Cyclizine
33%
Medicine and Dentistry
Motion Sickness
100%
Drug Therapy
20%
Antivertigo Agent
13%
Vertigo
6%
Pediatrics
6%
Brainstem
6%
Physical Disease by Body Function
6%
Histamine Antagonist
6%
Vestibular Nucleus
6%
Parenteral Drug Administration
6%
Cinnarizine
6%
Dimenhydrinate
6%
Promethazine
6%
Rectal Administration
6%
Cyclizine
6%
Diseases
6%
Pharmacology, Toxicology and Pharmaceutical Science
Motion Sickness
100%
Antivertigo Agent
13%
Antihistaminic Agent
6%
Dimenhydrinate
6%
Cinnarizine
6%
Physical Disease by Body Function
6%
Promethazine
6%
Cyclizine
6%
Vertigo
6%
Diseases
6%